Cytori has successfully begun its first ever U.S. approval trial and consistent with their experience in treating scleroderma in Europe, the patient tolerated the procedure well. Cytori, 08/25/2015. (Also see Scleroderma Clinical Trials: ADRC Injections/STAR)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.